PQ 852
852. Deputy William Aird asked the Minister for Health the current status of the reimbursement application for givinostat for the treatment of boys living with Duchenne muscular dystrophy; the timeline for a decision following consideration by the HSE Drugs Group; the steps being taken to ensure that there are no further delays in access should reimbursement be approved; whether eligibility criteria will be aligned with those applied by NICE in Northern Ireland to ensure equitable access for Irish patients; and if she will make a statement on the matter. [44974/26]
Introduced
16 June 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
16 June 2026
Summary
852. Deputy William Aird asked the Minister for Health the current status of the reimbursement application for givinostat for the treatment of boys living with Duchenne muscular dystrophy; the timeline for a decision following consideration by the HSE Drugs Group; the steps being taken to ensure that there are no further delays in access should reimbursement be approved; whether eligibility criteria will be aligned with those applied by NICE in Northern Ireland to ensure equitable access for Irish patients; and if she will make a statement on the matter. [44974/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 16 June 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-06-16/852/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-06-16/pq_852